GLPwatch

Protocol for Clinical GLP-1 Receptor PET/CT Imaging with [<sup>68</sup>Ga]Ga-NODAGA-Exendin-4.

Methods Mol Biol · 2023

Last updated 2026-05-28

This study describes a new imaging method using a radioactive tracer called [Ga]Ga-NODAGA-exendin-4 to detect GLP-1 receptors in the body. The tracer can be prepared quickly and forms a stable compound, allowing clear visualization of beta cells in the pancreas, insulinomas, and certain lesions linked to congenital hyperinsulinism through PET/CT scans.

AI summary of the abstract below.

JournalMethods Mol Biol, 2023
Citations9
Relative citation ratio1.71
NIH percentile69
Molecules

Abstract

Imaging with radiolabeled exendin enables detection and characterization of glucagon-like peptide 1 receptors (GLP-1Rs) in vivo with high specificity. The novel radiotracer [Ga]Ga-NODAGA-exendin-4 forms a stable complex after a simple and fast labeling procedure. Beta-cell mass in the islets of Langerhans can be visualized using [Ga]Ga-NODAGA-exendin-4, which is promising for research into diabetes mellitus (DM) pathophysiology. Furthermore, this radiotracer enables very sensitive detection of insulinomas, resulting from vast overexpression of GLP-1Rs, and seems promising for the detection of focal lesions in congenital hyperinsulinism (CHI). Here, we describe the procedures involved in [Ga]Ga-NODAGA-exendin-4 positron emission tomography (PET)/computed tomography (CT) imaging including the radiolabeling of the NODAGA-exendin conjugate with Ga, quality controls, and PET/CT.

Verbatim abstract via PubMed 36507990 ↗